These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69. [Cellular and molecular mechanism of cardiovascular disease resulting from hyperhomocysteinemia]. Gao L; Tang CS Sheng Li Ke Xue Jin Zhan; 2002 Oct; 33(4):335-8. PubMed ID: 12650071 [No Abstract] [Full Text] [Related]
70. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738 [TBL] [Abstract][Full Text] [Related]
73. [Homocysteinemia and vascular disease--a new risk factor is born]. Reis RP; Luís AS Rev Port Cardiol; 1999 May; 18(5):507-14. PubMed ID: 10418265 [TBL] [Abstract][Full Text] [Related]
74. [Homocysteine and cardiovascular risk]. Auer J; Berent R; Weber T; Lassnig E; Eber B Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594 [TBL] [Abstract][Full Text] [Related]
75. [Homocysteine and coronary artery disease]. Aro A Duodecim; 2003; 119(12):1131-5. PubMed ID: 12868359 [No Abstract] [Full Text] [Related]
78. [Risk factors for cardiovascular diseases: what is the role for homocysteine?]. Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357 [TBL] [Abstract][Full Text] [Related]